Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

GLP-1 therapies can cause hair loss, but hair often regrows after stopping or reducing the drug.

Effective weight loss during pregnancy is crucial for better maternal and fetal health.

New therapies for rare skin diseases show promise but need more research.

GLP-1 receptor agonists can cause skin and hair issues due to rapid weight loss, but these can be managed with proper care and treatments.

Combining lifestyle changes and medication is most effective for managing PCOS symptoms.

Treating hirsutism and acne in women with PCOS needs a personalized approach using oral contraceptives, antiandrogens, and sometimes metformin.

GLP-1 receptor agonists can help skin conditions but may cause hair loss and other skin issues.

Combining antidiabetic drugs, hormonal therapies, and lifestyle changes can improve health in women with PCOS.

Metabolic issues may trigger lymphocytic cicatricial alopecia, and treatments targeting these issues could help.

GLP-1 agonists may help treat certain skin conditions.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

PCOS treatment should be personalized based on individual symptoms and health goals.

GLP-1 receptor analogs may help improve metabolism and reproductive health in people with PCOS and obesity.

Mice skin has components that could help with hair growth and might be used for diabetes treatment.

Medications for PCOS don't seem to raise heart disease risk.

Semaglutide may help some skin disorders but can also cause skin issues.

GLP-1RAs may cause hair loss but could also help regrow hair in some cases.

A comprehensive, personalized approach is needed for treating female pattern hair loss and obesity, involving multiple medical disciplines and lifestyle changes.

SGLT2 inhibitors may help manage PCOS symptoms effectively.

Understanding and manipulating epigenetic changes can potentially lead to human organ regeneration therapies, but more research is needed to improve these methods and minimize risks.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

Methylene blue helps hair growth by protecting hair stem cells from stress.

Women with Polycystic Ovary Syndrome (PCOS) have a higher risk of developing type 2 diabetes due to insulin resistance.

Individualized treatments may help manage Dercum's disease symptoms.

Peptide-based hydrogels are promising for healing chronic wounds effectively.

Stem cell niches are crucial for regulating stem cell behavior and tissue health, and their decline can impact aging and cancer.

Glycemic control medications for Type 2 diabetes can affect skin conditions like psoriasis.

GLP-1 RAs help with diabetes and skin issues but can cause skin reactions and surgery challenges.

GLP-1 receptor agonists may cause hair loss, but more research is needed.

Drug repositioning is a promising way to quickly develop new treatments, especially for rare diseases.